Researcher, University of North Carolina at Chapel Hill
Appears in 1 story
Lead author of first randomized trial of semaglutide for alcohol use disorder
Drugs designed to control blood sugar and shrink waistlines may also quiet the cravings that drive addiction. A March 4 BMJ study of more than 600,000 U.S. veterans found GLP-1 users were 14 percent less likely to develop a new substance use disorder.
Updated May 30
No stories match your search
Try a different keyword
How would you like to describe your experience with the app today?
